Logo image
Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease
Journal article   Open access   Peer reviewed

Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease

Ticiana C Rodrigues, David M Maahs, Richard J Johnson, Diana I Jalal, Gregory L Kinney, Christopher Rivard, Marian Rewers and Janet K Snell-Bergeon
Diabetes care, Vol.33(11), pp.2471-2473
11/2010
DOI: 10.2337/dc10-1007
PMCID: PMC2963516
PMID: 20798338
url
https://doi.org/10.2337/dc10-1007View
Published (Version of record) Open Access

Abstract

To examine uric acid (UA) as a possible predictor of the progression of coronary artery calcification (CAC) using data from the prospective Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. CAC was measured by electron beam tomography at the baseline and at a follow-up 6.0±0.5 years later. The study population included 443 participants with type 1 diabetes and 526 control subjects who were free of diagnosed coronary artery disease at baseline. The presence of renal disease was defined by the presence of albuminuria and/or low glomerular filtration rate. In subjects without renal disease, serum UA predicted CAC progression (odds ratio 1.30 [95% CI 1.07-1.58], P=0.007) independent of conventional cardiovascular risk factors including diabetes and the presence of metabolic syndrome. Serum UA levels predict the progression of coronary atherosclerosis and may be useful in identifying who is at risk for vascular disease in the absence of significant chronic kidney disease.
Kidney Diseases Humans Middle Aged Coronary Artery Disease - pathology Adult Female Male Uric Acid - blood Coronary Artery Disease - blood Disease Progression

Details

Metrics

Logo image